TCF7L2 rs7903146 and PNPLA3 rs738409 gene variants confer the strongest risk for type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), respectively. This evidence concerns the gene TCF7L2 and metabolic dysfunction-associated steatotic liver disease.